Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Anja Conrad"'
Publikováno v:
OncoImmunology, Vol 7, Iss 8 (2018)
The signal adapter MyD88, an essential component of Toll-like receptor (TLR) signaling, is important for gut-microbiome interactions. However, its contribution to cancer and its cell-type specific functions are controversially discussed. Therefore, w
Externí odkaz:
https://doaj.org/article/9d90d68864e5430db44d635ba838f50c
Autor:
Anja Conrad
Publikováno v:
Praktische Theologie. 58:54-56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db633869e7cd0d53c40e8237ef9e55ab
https://doi.org/10.14315/prth-2023-580114
https://doi.org/10.14315/prth-2023-580114
Autor:
Anja Conrad
Publikováno v:
Pastoraltheologie. 111:97-108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9a5a1840f41325cbfb085374e749eb4
https://doi.org/10.13109/path.2022.111.3.97
https://doi.org/10.13109/path.2022.111.3.97
Autor:
Klaus-Peter Janssen, Tanja Bien, Klaus Dreisewerd, Ludger Johannes, Andrea Christel Machmüller, Anja Conrad, Markus Perl, Ulrich Nitsche, Jens Soltwisch, Johannes Müthing
Publikováno v:
Analytical Chemistry. 92:7096-7105
The main cellular receptors of Shiga toxins (Stxs), the neutral glycosphingolipids (GSLs), globotriaosylceramide (Gb3Cer/CD77) and globotetraosylceramide (Gb4Cer), are significantly upregulated in about half of the human colorectal carcinomas (CRC) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f3b5284f4d29f87cf0d7c60b7add125
https://doi.org/10.1021/acs.analchem.0c00480
https://doi.org/10.1021/acs.analchem.0c00480
Autor:
Julia Horstmann, Anna Brandtner, Rainer Blaser, Klaus A. Kuhn, Widya Johannes, Wilko Weichert, Melissa Schmidt, Frederik Wein, Andreas Lehmann, Florian Kohlmayer, Julia Slotta-Huspenina, Karl-Friedrich Becker, Birgit Linkohr, Michael Quante, Klaus-Peter Janssen, Konstantin Strauch, Maria Wiethaler, Nikole Radani, Akanksha Anand, Anja Conrad, Roland M. Schmid, Theresa Baumeister, Sebastian Lange, Anne S. Quante, Sophie Gerland
Publikováno v:
Diseases of the Esophagus. 32
SUMMARYRisk stratification in patients with Barrett's esophagus (BE) to prevent the development of esophageal adenocarcinoma (EAC) is an unsolved task. The incidence of EAC and BE is increasing and patients are still at unknown risk. BarrettNET is an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e567d74358dd650cc5a650fcfad43e0
https://doi.org/10.1093/dote/doz024
https://doi.org/10.1093/dote/doz024
Autor:
David Schnell, Dietmar Gansser, Raimund Külzer, Anne Weber, Gudrun Wallenstein, Sven Wind, Sabrina Wiebe, Atef Halabi, Anja Conrad
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics
Afatinib is an oral irreversible ErbB-Family Blocker indicated for treatment of patients with EGFR mutation positive advanced non-small cell lung cancer. This trial assessed whether renal impairment influences the pharmacokinetics and safety of afati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cdf6732a9d268c5227adfc3be9caa05
http://europepmc.org/articles/PMC5423921
http://europepmc.org/articles/PMC5423921
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 7, Iss 8 (2018)
OncoImmunology, Vol 7, Iss 8 (2018)
The signal adapter MyD88, an essential component of Toll-like receptor (TLR) signaling, is important for gut-microbiome interactions. However, its contribution to cancer and its cell-type specific functions are controversially discussed. Therefore, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d471426bfc19636e075b40482226d9
http://europepmc.org/articles/PMC6136867
http://europepmc.org/articles/PMC6136867
Autor:
Volkhard Kurowski, Franz Hartmann, Deepak Jain, Christina Thomsen, Anja Conrad, Peter W. Radke, Heribert Schunkert, Marko Remmel
Publikováno v:
Clinical research in cardiology : official journal of the German Cardiac Society. 97(4)
Treatment of coronary bifurcation lesions (CBL) remains challenging. This study sought to evaluate a novel dedicated stent system (Frontier™ stent) by angiographic and clinical comparison with the provisional T-stenting technique using drug-eluting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e904b9b5d32267748d08c8a036922b6
https://pubmed.ncbi.nlm.nih.gov/18046522
https://pubmed.ncbi.nlm.nih.gov/18046522